Pokrývková et (14) indicated that increased expression of PD-1 in CD8+ T cells conferred improved survival outcomes, and PD1 + CD8 + Cells are an independent prognostic marker in patients with head and neck cancer. The gene discussed is RPL17; the disease is head and neck cancer.